These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29209778)

  • 1. Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
    Zhao L; Zhao Z; Chen X; Li J; Liu J; Li G;
    Heart Vessels; 2018 May; 33(5):507-512. PubMed ID: 29209778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
    Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y
    BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay.
    Han YL; Liu JN; Jing QM; Ma YY; Jiang TM; Pu K; Zhao RP; Zhao X; Liu HW; Xu K; Wang G; Wang B; Sun RH; Wang J
    Cardiovasc Ther; 2013 Oct; 31(5):285-90. PubMed ID: 23634911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy study of prourokinase injection during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Jiang W; Xiong X; Du X; Ma H; Li W; Cheng F
    Coron Artery Dis; 2021 Jan; 32(1):25-30. PubMed ID: 32310850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Geng W; Zhang Q; Liu J; Tian X; Zhen L; Song D; Yang Y; Meng H; Wang Y; Chen J
    J Interv Cardiol; 2018 Apr; 31(2):136-143. PubMed ID: 29171086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Intracoronary Prourokinase Thrombolysis on Myocardial Perfusion and Vascular Endothelial Function in STEMI.
    Che S; Guo X; Lei Z; Lin S
    Clin Lab; 2024 Jul; 70(7):. PubMed ID: 38965967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
    Ouriel K; Kandarpa K; Schuerr DM; Hultquist M; Hodkinson G; Wallin B
    J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.
    Madhavan MV; Généreux P; Kirtane AJ; Xu K; Witzenbichler B; Mehran R; Stone GW
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):650-658. PubMed ID: 26124455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies with the new glycosylated recombinant prourokinase.
    Sasahara AA; Barker WM; Weaver WD; Hartmann J; Anderson JL; Reddy PS; Villiard EM
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):84S-93S. PubMed ID: 8770849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).
    Greco C; Pelliccia F; Tanzilli G; Tinti MD; Salenzi P; Cicerchia C; Schiariti M; Franzoni F; Speziale G; Gallo P; Gaudio C
    Am J Cardiol; 2013 Sep; 112(5):630-5. PubMed ID: 23711809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.
    Furlan A; Higashida R; Wechsler L; Gent M; Rowley H; Kase C; Pessin M; Ahuja A; Callahan F; Clark WM; Silver F; Rivera F
    JAMA; 1999 Dec; 282(21):2003-11. PubMed ID: 10591382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis.
    Priti K; Agrawal A; Ranwa BL
    Indian Heart J; 2017; 69(4):453-457. PubMed ID: 28822510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.
    Pelliccia F; Greco C; Tanzilli G; Viceconte N; Schiariti M; Gaudio C
    J Thromb Thrombolysis; 2021 Jan; 51(1):212-216. PubMed ID: 32472307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of recombinant human pro-urokinase and tirofiban on myocardial blood flow perfusion in ST elevation myocardial infarction patients receiving primary percutaneous coronary intervention: A one-center retrospective observational study.
    Yao Z; Li W; Cheng L; Cao M; Pang Z; Li Y
    Medicine (Baltimore); 2019 Jul; 98(27):e16143. PubMed ID: 31277114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmaco-invasive strategy with half-dose recombinant human prourokinase in treating patients with acute ST-segment elevation myocardial infarction (STEMI): The 2-year follow-up of bleeding events.
    Dou J; Yang HH; Wang XY; Luo DL
    Asian J Surg; 2024 Jun; 47(6):2950-2951. PubMed ID: 38418322
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preclinical fibrinolysis in patients with ST-segment elevation myocardial infarction in a rural region].
    Viergutz T; Grüttner J; Walter T; Weiss C; Haaff B; Pollach G; Madler C; Luiz T
    Anaesthesist; 2016 Sep; 65(9):673-80. PubMed ID: 27503306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-Procedural Thrombolysis in Myocardial Infarction Flow in Patients with ST-Segment Elevation Myocardial Infarction.
    Hashimoto T; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Yasuda S; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Uematsu M; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Toubaru T; Saku K; Oshima S; Nakai M; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Int Heart J; 2018 Sep; 59(5):920-925. PubMed ID: 30158385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden.
    Wang X; Liu H; Wu H; Xiao Y; Bai S; Li X; Li X; Zhang L; Chen T; Li H; Liu J; Du R
    Coron Artery Dis; 2020 Sep; 31(6):493-499. PubMed ID: 32073417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.